EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
20.06.24
/
50%
€7.48
Target price
20.06.25
-
Performance (%)
-6.79%
End price
21.06.25
€6.98
Summary
This prediction ended on 21.06.25 with a price of €6.98. With a performance of -6.79%, the BUY prediction by Cantor_Fitzgerald finished with a loss. Cantor_Fitzgerald has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -4.688% | -4.688% | 31.693% |
| iShares Core DAX® | -3.173% | 1.229% | 2.539% |
| iShares Nasdaq 100 | -1.006% | 0.381% | 32.247% |
| iShares Nikkei 225® | -3.600% | 1.005% | 59.535% |
| iShares S&P 500 | 0.214% | 2.924% | 24.524% |
Comments by Cantor_Fitzgerald for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.20
08.07.26
08.07.26
€41.17
08.07.27
08.07.27
6.56%
13.07.26
13.07.26
Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.20
14.09.23
14.09.23
€29.02
14.09.24
14.09.24
-18.55%
15.09.24
15.09.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.00
31.08.23
31.08.23
€28.59
31.08.24
31.08.24
-13.24%
01.09.24
01.09.24